Article

Biosimilar Prescribing Issues Highlight Week in Specialty Pharmacy

Author(s):

Davy James, Managing Editor

Top articles of the week on Specialty Pharmacy Times.

[<a href="//storify.com/pharmacytimes/biosimilar-prescribing-issues-highlight-week-in-sp" target="_blank">View the story "Biosimilar Prescribing Issues Highlight Week in Specialty Pharmacy" on Storify</a>]

Related Videos
Related Content
FDA Approves Prademagene Zamikeracel, First and Only Cell-Based Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa
April 29th 2025

FDA Approves Prademagene Zamikeracel, First and Only Cell-Based Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa

Aislinn Antrim, Managing Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Portrait of a male pharmacist working at the counter in pharmacy | Image Credit: © Zamrznuti tonovi - stock.adobe.com
April 29th 2025

Asembia AXS25: Community Pharmacists Can Optimize Specialty Pharmacy Care

Luke Halpern, Assistant Editor
Pharmacy Focus: World Psychedelics Day
June 14th 2024

Pharmacy Focus: World Psychedelics Day

Ashley Gallagher, Editor
Gout tophus, photomicrograph showing amorphous, eosinophilic material with a foreign-body giant cell reaction and inflammation
April 25th 2025

JAK1 Inhibitor NS-229 Granted FDA Orphan Drug Designation to Treat Allergic Autoimmune Condition

Luke Halpern, Assistant Editor
Nasopharyngeal carcinoma -- Image credit: Matthieu | stock.adobe.com
April 24th 2025

FDA Approves Penpulimab-Kcqx for Indications in Nonkeratinizing Nasopharyngeal Carcinoma

Gillian McGovern, Associate Editor